SynsoryBio
"If-then" conditional logic for protein drugs
SynsoryBio is active in the healthcare space based in Boston, MA, USA.
Profile
SynsoryBio is creating next generation, protein therapeutics that sense where they are in the body and only activate at diseased tissue. This technology platform has the potential to expand the therapeutic window of highly potent drugs and apply to many diseases such as cancer and autoimmune disorders.
SynsoryBio is positioned in healthcare, a segment that rewards a clear, focused offering.
Boston, MA, USA is where the company is located.
The company is listed at the Winter 2024 stage of development.
Recorded headcount: 2 employees.
Directory analysis
SynsoryBio is developing protein therapeutics that incorporate conditional logic to activate only within diseased tissues, aiming to improve the safety and efficacy of potent drugs. The company’s platform seeks to expand therapeutic windows for treatments of conditions such as cancer and autoimmune disorders. Based in Boston, the startup currently has a small team of two employees.
Positioning: With a focused technology niche, SynsoryBio positions itself within the precision medicine and protein therapeutics space, targeting a market that values targeted drug delivery. Its early-stage status and limited team size suggest a high development risk but potential for significant impact if the platform proves effective.
Note: SynsoryBio is a Boston‑based startup creating protein drugs that activate only at diseased sites.
Auto-generated directory analysis from public data · updated 11 Oct 2026. Informational only, not investment advice.
| Sector | Healthcare |
|---|---|
| Headquarters | Boston, MA, USA |
| Country | USA |
| Employees | 2 |
| Stage | Winter 2024 |
Website: www.synsorybio.com
Browse related
Create a free account